CONMED Corporation Market Cap ($1.08 Billion)
Market Cap & Net Worth: CONMED Corporation (CNMD)
CONMED Corporation market cap. CONMED Corporation (NYSE:CNMD) has a market capitalization of $1.08 Billion ($1.08 Billion) as of November 8, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #8255 globally and #2426 in its home market, demonstrating a 12.64% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CONMED Corporation's stock price $51.50 by its total outstanding shares 30109194 (30.11 Million). Also see how efficiently does CONMED Corporation generate cash for how efficiently the company converts equity into cash flow.
CONMED Corporation Market Cap History (2015–2026)
CONMED Corporation market cap history from 2015 to 2026. Data shows growth from $1.21 Billion to $1.55 Billion (1.18% CAGR). Check CNMD stock price and chart for real-time trading data and today's change.
Index Memberships
CONMED Corporation is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P Small-Cap 600 Index
SML
|
$1.51 Trillion | 0.14% | #440 of 602 |
Weight: CONMED Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
CONMED Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CONMED Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore CNMD net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.89x
CONMED Corporation's market cap is 0.89 times its annual revenue
Latest Price to Earnings (P/E) Ratio
25.98x
CONMED Corporation's market cap is 25.98 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.23 Billion | $763.52 Million | $14.66 Million | 1.61x | 84.07x |
| 2017 | $1.45 Billion | $796.39 Million | $55.49 Million | 1.82x | 26.07x |
| 2018 | $1.84 Billion | $859.63 Million | $40.85 Million | 2.14x | 45.11x |
| 2019 | $3.24 Billion | $955.10 Million | $28.62 Million | 3.39x | 113.14x |
| 2020 | $3.28 Billion | $862.46 Million | $9.52 Million | 3.80x | 344.20x |
| 2021 | $4.17 Billion | $1.01 Billion | $62.54 Million | 4.13x | 66.70x |
| 2022 | $2.63 Billion | $1.05 Billion | -$80.58 Million | 2.51x | N/A |
| 2023 | $3.27 Billion | $1.24 Billion | $64.46 Million | 2.63x | 50.76x |
| 2024 | $2.06 Billion | $1.31 Billion | $132.42 Million | 1.58x | 15.56x |
| 2025 | $1.22 Billion | $1.37 Billion | $47.05 Million | 0.89x | 25.98x |
Competitor Companies of CNMD by Market Capitalization
Companies near CONMED Corporation in the global market cap rankings as of November 8, 2026. Also see total assets of CONMED Corporation for a full breakdown of the balance sheet.
Key companies related to CONMED Corporation by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #109 | Abbott Laboratories | NYSE:ABT | $191.15 Billion | $109.93 |
| #188 | Stryker Corporation | NYSE:SYK | $124.99 Billion | $325.87 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $101.80 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of CONMED Corporation (2015–2026)
Market capitalization of CONMED Corporation from 2015 to today. Between 2015 and today, CONMED Corporation's market cap moved from $1.21 Billion to $ 1.55 Billion, with a yearly change of 1.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.55 Billion | +26.85% |
| 2025 | $1.22 Billion | -40.68% |
| 2024 | $2.06 Billion | -37.02% |
| 2023 | $3.27 Billion | +24.45% |
| 2022 | $2.63 Billion | -36.98% |
| 2021 | $4.17 Billion | +27.35% |
| 2020 | $3.28 Billion | +1.16% |
| 2019 | $3.24 Billion | +75.71% |
| 2018 | $1.84 Billion | +27.39% |
| 2017 | $1.45 Billion | +17.33% |
| 2016 | $1.23 Billion | +2.19% |
| 2015 | $1.21 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of CONMED Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.08 Billion USD |
| MoneyControl | $1.08 Billion USD |
| MarketWatch | $1.08 Billion USD |
| marketcap.company | $1.08 Billion USD |
| Reuters | $1.08 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation an… Read more